• FirefoxInstall the new Firefox »
  •  Dow Down 0.45% Nasdaq Down 0.49%

    Celgene Corporation (CELG)

    -NasdaqGS
    121.53 Down 1.82(1.48%) Feb 27, 4:00PM EST
    |After Hours : 121.53 0.00 (0.00%) Feb 27, 7:22PM EST
    Add to Portfolio
    Prev Close:123.35
    Open:122.81
    Bid:119.50 x 100
    Ask:N/A
    1y Target Est:137.54
    Beta:1.84
    Earnings Date:Apr 22 - Apr 27 (Est.)
    Day's Range:120.77 - 123.14
    52wk Range:66.85 - 125.45
    Volume:4,288,968
    Avg Vol (3m):5,537,310
    Market Cap:97.30B
    P/E (ttm):50.85
    EPS (ttm):2.39
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Comparison

    Symbol% ChgMkt Cap
    CELGDown 1.48%97.30B
    JNJDown 0.28%285.03B

    Key Statistics

    Forward P/E (1 yr):19.26
    P/S (ttm):12.87
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-15) :4.83
    Quarterly EPS Est (Mar-15) :1.07
    Mean Recommendation*:1.8
    PEG Ratio (5 yr expected):0.99

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Celgene Corporation, a biopharmaceutical company, discovers, develops, and commercializes therapies to treat cancer and inflammatory diseases in the United States and Internationally. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback